The Use of Metformin in the Treatment of Antipsychotic-Induced Weight Gain in Schizophrenia (The METS Study)
Public ClinicalTrials.gov record NCT00816907. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.
Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.
Official title
Metformin in the Treatment of Antipsychotic-Induced Weight Gain in Schizophrenia (METS) - Pilot Study
Study identification
- NCT ID
- NCT00816907
- Recruitment status
- Completed
- Study type
- Interventional
- Phase
- Phase 4
- Lead sponsor
- National Institute of Mental Health (NIMH)
- NIH
- Enrollment
- 146 participants
Conditions and interventions
Conditions
Interventions
- Metformin Drug
- Placebo Drug
Drug
Eligibility (public fields only)
- Age range
- 18 Years to 65 Years
- Sex
- All
- Healthy volunteers
- Healthy volunteers not accepted
This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.
Study timeline
- Start date
- Dec 31, 2008
- Primary completion
- Jan 31, 2010
- Completion
- Feb 28, 2010
- Last update posted
- Mar 26, 2013
2009 – 2010
United States locations
- U.S. sites
- 16
- U.S. states
- 12
- U.S. cities
- 16
| Facility | City | State | ZIP | Site status |
|---|---|---|---|---|
| Stanford University | Palo Alto | California | 94305 | — |
| Mental Health Advocates | Boca Raton | Florida | 33431 | — |
| University of Iowa | Iowa City | Iowa | 52242 | — |
| Clinical Research Institute | Wichita | Kansas | 67207 | — |
| Clinical Insights | Glen Burnie | Maryland | 21061 | — |
| Freedom Trail Clinic | Boston | Massachusetts | 02114 | — |
| University of Massachusetts | Worcester | Massachusetts | 01605 | — |
| University of Minnesota School of Medicine | Minneapolis | Minnesota | 55454 | — |
| New Mexico VA Healthcare System | Albuquerque | New Mexico | 87108 | — |
| Research Foundation for Mental Hygiene | New York | New York | 10032 | — |
| University of Rochester | Rochester | New York | 14623 | — |
| University of Cincinnati | Cincinnati | Ohio | 45267 | — |
| Vanderbilt University Schizophrenia Research | Nashville | Tennessee | 37212 | — |
| University of Texas Southwestern Medical Center | Dallas | Texas | 75235 | — |
| Baylor College of Medicine | Houston | Texas | 77030 | — |
| University of Texas Health Science Center at San Antonio | San Antonio | Texas | 78229 | — |
Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.
About this trial record page
- What this page shows
- Public field values for ClinicalTrials.gov record NCT00816907, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
- What this page does not do
- No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
- Where the data comes from
- Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
- Last refresh
- Last update posted Mar 26, 2013 · Synced May 12, 2026
Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.
Open the official record
The complete protocol, eligibility criteria, and contact information for NCT00816907 live on ClinicalTrials.gov.